SCHEMBL6136514

SCHEMBL6136514

CCOC(=O)CCNCc1ccc2c(c1)OCCO2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.53
TP53 P04637 1/20 0.53
GLA P06280 1/20 0.53
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 5/20 0.49
MAPT P10636 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
USP2 O75604 2/20 0.49
LMNA P02545 2/20 0.49
HSD17B10 Q99714 2/20 0.49
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.48
POLB P06746 1/20 0.48
HTT P42858 1/20 0.47
HPGD P15428 2/20 0.47
CNR2 P34972 1/20 0.47
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10956809 0.83 NPC1 (0.55) NPC1TP53GLARAB9ASMN1; SMN2
SCHEMBL11035690 0.81 POLB (0.54) NPC1RAB9AALDH1A1MAPTMEN1
SCHEMBL16839695 0.81 LTA4H (0.41) ALDH1A1MAPTMEN1KMT2AUSP2
SCHEMBL4140012 0.80 RAB9A (0.58) NPC1TP53GLARAB9ASMN1; SMN2
SCHEMBL6324177 0.80 MEN1 (0.55) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL3103203 0.80 FAAH (0.54) NPC1TP53GLARAB9ASMN1; SMN2
SCHEMBL16839712 0.79 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1MAPTLMNAALOX15
SCHEMBL13607688 0.79 PKM (0.47) NPC1TP53GLARAB9ASMN1; SMN2
SCHEMBL11922718 0.78 DPP7 (0.51) ALDH1A1KMT2APDCD1CD274TRPV1
SCHEMBL16839656 0.77 RAB9A (0.44) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042279-B1 SUBSTITUTED BETA-ALANINES AVENTIS PHARMA LTD (GB) 2005-03-02 EP disclosed
US-6352977-B1 ALANINE WITH PRODRUGS AVENTIS PHARMA LIMITED (GB) 2002-03-05 US disclosed
EP-1042279-A1 SUBSTITUTED BETA-ALANINES Aventis Pharma Limited (GB) 2000-10-11 EP disclosed
WO-1999033789-A1 SUBSTITUTED β-ALANINES AVENTIS PHARMA LIMITED (GB) 1999-07-08 WO disclosed